MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gyutae Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biotechnology, KU Institute of Technology, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Rett Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Konkuk University.
Abstract (Originalsprache)
Rett syndrome is a severe neurodevelopmental disorder that occurs primarily in females and is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene located on the X chromosome. Though MECP2 acts as a representative transcriptional regulator and affects gene expression both directly and indirectly, a complete understanding of this disease and the treatment mechanism has not been established yet. MECP2 plays a particularly important role in synaptic development, neuronal maturation, and epigenetic regulation in the brain. In this study, we summarize the molecular structure of MECP2, mutation-specific pathogenesis, and the role of MECP2 in regulating chromatin remodeling, RNA splicing, and miRNA processing to provide a comprehensive understanding of Rett syndrome. Additionally, we describe abnormal phenotypes manifested in various brain regions and other tissues owing to MECP2 dysfunction. Finally, we discuss current and future therapeutic approaches, including AAV-based gene therapy, RNA editing, X chromosome reactivation, and pharmacological interventions. Understanding the diverse functions and pathological mechanisms of MECP2 provides an important foundation for developing targeted therapies for Rett syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell and Regenerative Biotechnology, KU Institute of Technology, Konkuk University, Seoul 05029, Republic of Korea.
- 3D Tissue Culture Research Center, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Gyutae Choi, Sanghyo Lee, Jeung Tae Do
Förderung
- Konkuk University
Zitieren
APA
Choi, G., Lee, S., Yoo, S., & Do, J. T. (2025). MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178277
Vancouver
Choi G, Lee S, Yoo S, Do JT. MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178277
BibTeX
@article{Choi2025,
author = {Choi, Gyutae and Lee, Sanghyo and Yoo, Seungjae and Do, Jeung Tae},
title = {MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178277}
}
EUVIMED